NCT04539834 is a clinical trial of electrolytes in Electrolyte Imbalance, sponsored by Zagazig University.

Who is sponsoring NCT04539834?

NCT04539834 is sponsored by Zagazig University.

What drugs are being tested in NCT04539834?

Interventions in NCT04539834: electrolytes.

What condition does NCT04539834 study?

NCT04539834 studies Electrolyte Imbalance.

Is NCT04539834 still recruiting?

NCT04539834 is currently completed. Last updated 23 November 2021.

Last reviewed 2021-11-23 · How we verify

NCT04539834

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Electrolyte State in Patients With COVID-19

Completed Last updated 23 November 2021

What this trial tests

trial testing electrolytes in Electrolyte Imbalance in 983 participants. Completed in 30 October 2021.

Timeline

1 May 2020

Primary endpoint
1 August 2021

30 October 2021

Quick facts

Lead sponsor	Zagazig University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	983
Start date	1 May 2020
Primary completion	1 August 2021
Estimated completion	30 October 2021
Sites	1 location across Egypt

Drugs / interventions tested

electrolytes

Conditions studied

Electrolyte Imbalance — all drugs for Electrolyte Imbalance →

Sponsor

Zagazig University

Who can join

Adults 18 to 80, any sex, with Electrolyte Imbalance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Initial case reports and cohort studies have described many clinical characteristics of patients with coronavirus disease 2019 (COVID-19), an emerging infectious disorder caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In early COVID-19 studies, some evidence has been provided that electrolyte disorders may also be present upon patients' presentation, including sodium, potassium, chloride and calcium abnormalities the aim of the study is Identification of elements that affect COVID-19 pathology to improve survival and decrease mortality rate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04539834 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 23 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04539834.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing